Coronavirus

Is preferred equity the covid-19 crisis’s white knight?

The niche strategy is coming into its own, as it did back in the global financial crisis.

Paul Hastings: Dealing with the denominator effect and LP defaults

GPs should be aware of right of first refusal clauses and PTP issues when processing transfer requests from LPs brought about by the covid-19 crisis.

Secondaries buyers seek bounty amid coronavirus chaos

Buyers with an appetite for unfunded commitments could be an early beneficiary of coronavirus-related volatility.

3i-managed Action’s troubles highlight single-asset risk

The retailer at the centre of one of last year’s largest single-asset deals is preparing for a ‘very tough’ Q2.

Private equity braces for the denominator effect

Limited partners who have piled into the asset class in recent years could be left severely overweighted in private equity unless public markets see a significant recovery.

PODCAST: How covid-19 is hitting private markets

Are private asset classes better positioned to weather the crisis? Our senior editorial teams covering PE, private debt, infrastructure, real estate and secondaries provide insight.

GP-leds, it’s time to prove your worth

The GP-led secondaries market has long touted itself as a creative panacea for managers and LPs; in this challenging period it’s time to step up to the plate.

Secondaries buyers expect VC fire sale

Overall secondaries market volume is expected to drop by about 30% this year, according to a survey by Setter Capital.

How to value LP stakes in light of covid-19

David Larsen, a managing director at Duff & Phelps, says investors should seek guidance from their GPs as to likely discounts.

Partners Group ‘ecstatic’ about buying opportunity brought on by crisis

The market is a rare bright spot amid coronavirus-related uncertainty, according to the firm’s annual results call on Tuesday.